Company / AR per Share
PLUS THERAPEUTICS, INC. AR per Share History
FY2011-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.03
FY2018
5-year range
$0.00 / $0.10
FY2014-FY2018
Trend
+3358.7%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
AR per Share changed +3359% YoY in FY2018, a notable deviation from the 7-year average annual change of +573%.
Based on SEC 10-K filings.
0.03 in FY2018 with a 5-year CAGR of -16.8%.
Declined from $0.10 to $0.03 over the past 2 years.
AR per Share over time
Growth rates
- 3-Year CAGR
- +33.3%
- 5-Year CAGR
- -16.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2018, ar per share increased 3358.7% year-over-year.
- Peak ar per share was recorded in FY2016.
- Lowest ar per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -2.46 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2018 | $0.03 | +3358.7% |
| FY2017 | $0.00 | -99.2% |
| FY2016 | $0.10 | +802.0% |
| FY2015 | $0.01 | -39.3% |
| FY2014 | $0.02 | -72.3% |
| FY2013 | $0.06 | -9.2% |
| FY2012 | $0.07 | +73.9% |
| FY2011 | $0.04 | - |
As of FY2018 · SEC 10-K · Updated Jun 28, 2026